In the US, Bufferin (aspirin systemic) is a member of the following drug classes: platelet aggregation inhibitors, salicylates and is used to treat Angina, Angina Pectoris Prophylaxis, Ankylosing Spondylitis, Antiphospholipid Syndrome, Aseptic Necrosis, Back Pain, Fever, Heart Attack, Ischemic Stroke, Ischemic Stroke - Prophylaxis, Juvenile Rheumatoid Arthritis, Kawasaki Disease, Myocardial Infarction - Prophylaxis, Niacin Flush, Osteoarthritis, Pain, Prosthetic Heart Valves - Thrombosis Prophylaxis, Prosthetic Heart Valves - Mechanical Valves - Thrombosis Prophylaxis, Revascularization Procedures - Prophylaxis, Rheumatic Fever, Rheumatoid Arthritis, Sciatica, Spondyloarthritis, Systemic Lupus Erythematosus, Thromboembolic Stroke Prophylaxis and Transient Ischemic Attack.
Ingredient matches for Bufferin
Acetylsalicylic Acid is reported as an ingredient of Bufferin in the following countries:
- United States
Acetylsalicylic Acid aluminium (a derivative of Acetylsalicylic Acid) is reported as an ingredient of Bufferin in the following countries:
Paracetamol is reported as an ingredient of Bufferin in the following countries:
Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.